Should I Buy CNXC? CNXC 2026 Analysis

Should You Buy Concentrix Corp (CNXC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

38.620

1 Day change

6.33%

52 Week Range

65.570

Analysis Updated At

2026/01/28

CNXC is NOT a good buy right now for a beginner long-term investor who wants to deploy capital immediately. The stock is in a clear downtrend with accelerating bearish momentum, and the latest quarter shows severe earnings deterioration (large net loss), which increases uncertainty. Without Intellectia buy signals and with bearish options volume skew, the risk/reward for buying today is unfavorable.

Technical Analysis

Price/Trend: CNXC is down sharply today (-9.54% to 37.633) and remains in a bearish trend (SMA_200 > SMA_20 > SMA_5), indicating persistent downside structure. Momentum: MACD histogram is negative (-0.358) and expanding lower, confirming bearish momentum is strengthening. RSI: RSI_6 at 29.609 suggests the stock is near oversold/weak territory, which can allow bounces, but oversold alone is not a durable long-term entry signal when trend and MACD are bearish. Key levels: Pivot 41.185 is well above price (overhead resistance). Nearby supports: S1 38.782 (already below today’s price) and S2 37.297 (very close). A clean break below ~37.3 would signal further downside. Intellectia Proprietary Trading Signals - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently. Pattern-based forward bias (provided): Similar-pattern probabilities imply mild downside ahead (-2.27% next week; -3.95% next month), aligning with the current bearish technicals.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Sentiment read: Open interest put/call of 0.81 suggests positioning is not extremely bearish longer-term (more call OI than put OI). However, the put/call ratio on TODAY’S volume is very high (3.73) with puts dominating activity (put volume 693 vs call volume 186), which is a near-term bearish/hedging signal. Volatility: 30D IV ~60.97 vs historical vol ~40.07, with IV percentile 72.8—options are pricing elevated near-term risk. This typically coincides with uncertainty and can accompany further downside or big swings rather than stable accumulation.

Technical Summary

Sell

Buy

Positive Catalysts

- Oversold/weak RSI conditions can produce short-term rebounds.
- Revenue grew YoY in the latest quarter (2025/Q4 +4.29%), and gross margin improved (34.31, +10.43% YoY), which is a constructive operating signal if losses normalize.
- Hedge funds and insiders are reported as Neutral (no strong selling pressure indicated by those datasets).

Neutral/Negative Catalysts

- Strong bearish trend: moving averages stacked bearishly and MACD downside momentum is expanding.
- Large one-day drop (-9.54%) suggests the market is repricing risk aggressively.
- Options flow is bearish near-term (put volume dominates strongly).
- No recent news catalysts provided to justify an immediate reversal.
- No supportive Intellectia buy signals today (no AI Stock Picker buy, no SwingMax entry).
- No recent congress trading data available (no signal of influential accumulation).

Financial Performance

Latest quarter: 2025/Q4. - Revenue: 2,552,925,000 (+4.29% YoY) — modest top-line growth. - Net Income: -1,479,384,000 (-1432.55% YoY) — major deterioration into a very large loss. - EPS: -23.83 (-1485.47% YoY) — extremely weak profitability. - Gross Margin: 34.31 (+10.43% YoY) — margin improved, but it did not translate into earnings. Overall: The growth trend on revenue/margins is positive, but the collapse in net income/EPS dominates the investment case and helps explain the heavy selloff and elevated IV.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating/price target trend data was provided, so changes in ratings and targets cannot be confirmed from this dataset. Wall Street-style pros (based on provided fundamentals): improving gross margin and modest revenue growth. Cons: severe profitability breakdown (massive net loss and EPS collapse) and bearish price/flow signals, which would likely keep professional sentiment cautious until earnings normalize.

3 Analyst Rating

Wall Street analysts forecast CNXC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNXC is 57.33 USD with a low forecast of 54 USD and a high forecast of 62 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 36.320

Low

Averages

57.33

High

Current: 36.320

Low

Averages

57.33

High

Baird

David Koning

Outperform

NULL

downgrade

$75 -> $62

AI Analysis

2025-09-29

Reason

Baird

David Koning

Price Target

$75 -> $62

AI Analysis

2025-09-29

downgrade

Outperform

NULL

Reason

Baird analyst David Koning lowered the firm's price target on Concentrix to $62 from $75 and keeps an Outperform rating on the shares. The firm updated its estimates following mixed Q3 results.

BofA

Neutral

downgrade

$61 -> $54

2025-09-29

Reason

BofA

Price Target

$61 -> $54

2025-09-29

downgrade

Neutral

Reason

BofA lowered the firm's price target on Concentrix to $54 from $61 and keeps a Neutral rating on the shares. The company reported a sales beat in Q3 but its operating margin missed estimates on lower volumes, the analyst tells investors in a research note. The firm believes Concentrix's generative artificial intelligence based tools and synergies from the Webhelp acquisition are helping offset macro headwinds.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CNXC

Unlock Now

CNXC Should I Buy

CNXC Should I Buy

Should You Buy Concentrix Corp (CNXC) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch